Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Calian Reports Results for the First Quarter
-
Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results
-
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
-
3D Systems Announces Date of Fourth Quarter and Full Year 2023 Financial Results
-
Statement from Ontario and Canadian road builders in response to Minister Guilbeault’s irresponsible comments
-
Marathon Digital Holdings Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
-
Transocean Ltd. Provides Quarterly Fleet Status Report
-
NurExone Launches Licensing Efforts for ExoTherapy Platform
-
Kadant Reports Fourth Quarter and Fiscal Year 2023 Results
-
January 2024 Retail Sales Results Reflect Altered Shopping Patterns, Reports Circana
-
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical
-
Occidental Announces Fourth Quarter 2023 Results
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Kaival Brands Provides Business Update in Letter to Shareholders
-
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical
-
Palomar Holdings, Inc. Reports Fourth Quarter & Full Year 2023 Results
-
Forward Reports Fiscal 2024 First Quarter Results
-
Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Retail Opportunity Investments Corp. Reports 2023 Results
-
Compass Diversified Announces Fourth Quarter and Full Year 2023 Earnings and Conference Call Information
-
Westwood Holdings Group Reports Fourth Quarter and Full Year 2023 Results
-
Bridgeline Announces Financial Results for the First Quarter of Fiscal 2024
-
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
-
Udemy Reports Fourth Quarter and Full Year 2023 Results
-
IRTC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
-
MYR Group Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
-
Udemy Announces Share Repurchase Program
-
Oaktree Specialty Lending Corporation Announces Tax Character of Distributions for Calendar Year 2023
-
Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocul
-
iPower Reports Fiscal Second Quarter 2024 Results
-
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
-
Enphase Energy Applauds Dutch Senate’s Decision to Extend Solar Net Metering
-
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
-
SuRo Capital Corp. Will Commence a Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Shares of its Common Stock
-
Prime Medicine Announces Proposed Public Offering of Common Stock
-
Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
Getty Realty Corp. Announces Fourth Quarter and Full Year 2023 Results
-
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
-
1stDibs Appoints Everette Taylor to Its Board of Directors
-
Sovos Brands Announces Fourth Quarter and Fiscal Year 2023 Earnings Date
-
Fidus Investment Corporation Declares First Quarter 2024 Dividend
-
Amwell Announces Results for Fourth Quarter and Full Year 2023
-
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
Monarch Casino & Resort Reports 2023 Fourth Quarter Financial Results
-
Upwork Reports Fourth Quarter and Full Year 2023 Financial Results
-
Monroe Capital Corporation Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
NMI Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
